Skip to main content

Series A Therapeutics Companies

Explore 233 therapeutics startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
233
Total Funding
$1.0B
Avg Funding
$41.5M
Cities
23

Export 233 Series A Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Reykjavík, Iceland
$27.5M
raised

Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Doylestown, United States

IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$86.0M
raised

Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Tampa, United States
$5.8M
raised

Inflammx Therapeutics is a biotechnology startup company.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$200.0M
raised

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Copenhagen, Denmark
$20.6M
raised

Neumirna Therapeutics is a pharmaceutical company that develops therapeutics for the treatment of neurological diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

$955K
raised

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$3.0M
raised

Gabaeron is a biopharmaceutical business that develops therapeutics for neurological illnesses based on stem cells and small chemicals.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States
$100.0M
raised

Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$4.2M
raised

Greenlight Health is a digital health platform that helps researchers and clinicians create validated real-world programs.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Perugia, Italy
$5.2M
raised

TES Pharma is a research-based biopharmaceutical company.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Abingdon, United Kingdom
$60.0M
raised

Akamis Bio is a clinical-stage oncology company.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$84.1M
raised

Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Montpellier, France
$42.0M
raised

CILcare specializes in providing drug solutions for hearing and ear disorders.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Hombrechtikon, Switzerland

PreComb develops technologies to optimally adapt the therapies to each patient for difficult-to-treat cancers.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Aurora, United States
$14.0M
raised

OncoVerity focuses on optimizing and advancing the development of cusatuzumab, a novel anti-CD70 antibody.

Nov 2024
Series A

Founder Contacts

41,000+ verified contacts

Aye, Belgium
$57.2M
raised

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

Nov 2024
Series A

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$76.5M
raised

Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.

Oct 2024
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Oct 2024
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$43.0M
raised

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

Oct 2024
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 233 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Ness Ziona, Israel
$10.0M
raised

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

West Lafayette, United States
$9.8M
raised

Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$65.0M
raised

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

$35.0M
raised

Radiant is a biotechnology company developing the next generation of multi-specificity.

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

Coventry, United Kingdom
$13.1M
raised

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 233 companies

Ready to Connect with Series A Therapeutics Startups?

Get verified founder emails, funding details, and company data for 233 series a therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked